New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 4, 2013
05:36 EDTCPHDCepheid downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray downgraded Cepheid on concerns the company's Q4 results and FY13 outlook could miss expectations. The firm lowered its price target for shares to $34 from $42.
News For CPHD From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 31, 2014
10:39 EDTCPHDCepheid management to meet with Craig Hallum
Subscribe for More Information
October 28, 2014
07:22 EDTCPHDCepheid to collaborate with FIND and Rutgers for novel tuberculosis test
Cepheid, FIND, and Rutgers New Jersey Medical School, will collaborate to develop Xpert MTB/RIF Ultra, a next-generation test for Mycobacterium tuberculosis with increased sensitivity to aid in detection of patients with smear-negative TB, which is often associated with HIV co-infection. The collaboration is also receiving additional support from the National Institute of Allergy and Infectious Diseases at the NIH. Xpert MTB/RIF Ultra is expected to be available to the HBDC market in 1H16.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use